Accurate Wealth Management LLC Sells 884 Shares of McKesson Corporation $MCK

Accurate Wealth Management LLC decreased its holdings in McKesson Corporation (NYSE:MCK) by 22.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,044 shares of the company’s stock after selling 884 shares during the period. Accurate Wealth Management LLC’s holdings in McKesson were worth $2,484,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in the stock. GGM Financials LLC bought a new stake in shares of McKesson in the 3rd quarter valued at about $25,000. State of Wyoming purchased a new stake in shares of McKesson during the second quarter valued at $29,000. Hopwood Financial Services Inc. acquired a new position in shares of McKesson in the 3rd quarter valued at $31,000. Board of the Pension Protection Fund purchased a new position in McKesson in the 4th quarter worth $33,000. Finally, Vermillion & White Wealth Management Group LLC acquired a new stake in McKesson during the 3rd quarter worth about $33,000. 85.07% of the stock is currently owned by institutional investors.

McKesson Stock Down 0.4%

MCK opened at $860.41 on Friday. McKesson Corporation has a 52 week low of $637.00 and a 52 week high of $999.00. The business’s 50 day moving average is $907.62 and its two-hundred day moving average is $838.81. The firm has a market cap of $105.39 billion, a price-to-earnings ratio of 24.75, a price-to-earnings-growth ratio of 1.39 and a beta of 0.38.

McKesson (NYSE:MCK) last announced its earnings results on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, beating analysts’ consensus estimates of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The business had revenue of $106.16 billion for the quarter, compared to analysts’ expectations of $105.98 billion. During the same period in the previous year, the company posted $8.03 EPS. The company’s quarterly revenue was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Equities analysts expect that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be paid a dividend of $0.82 per share. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date of this dividend is Monday, March 2nd. McKesson’s dividend payout ratio is 9.43%.

Insider Activity at McKesson

In other McKesson news, EVP Thomas L. Rodgers sold 276 shares of the stock in a transaction dated Monday, January 5th. The shares were sold at an average price of $816.18, for a total value of $225,265.68. Following the completion of the transaction, the executive vice president directly owned 2,268 shares of the company’s stock, valued at approximately $1,851,096.24. This trade represents a 10.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Leann B. Smith sold 190 shares of the stock in a transaction that occurred on Tuesday, February 17th. The shares were sold at an average price of $945.00, for a total transaction of $179,550.00. Following the completion of the sale, the executive vice president owned 2,989 shares in the company, valued at $2,824,605. This represents a 5.98% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 3,868 shares of company stock valued at $3,743,820 in the last ninety days. Company insiders own 0.08% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently commented on the company. JPMorgan Chase & Co. upped their target price on McKesson from $983.00 to $1,107.00 and gave the company an “overweight” rating in a research report on Tuesday, February 10th. Morgan Stanley reaffirmed an “overweight” rating and set a $966.00 price target on shares of McKesson in a research report on Thursday, January 29th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of McKesson in a report on Wednesday, December 10th. TD Cowen raised their price target on shares of McKesson from $1,000.00 to $1,012.00 and gave the company a “buy” rating in a research note on Thursday, February 5th. Finally, Barclays boosted their price objective on McKesson from $960.00 to $1,050.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 18th. Thirteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $960.93.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.